Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar 9:11:625-35.
doi: 10.2147/NDT.S78696. eCollection 2015.

Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial

Vahid Farnia  1 , Mehdi Shirzadifar  2 , Jalal Shakeri  1 , Mansour Rezaei  3 , Hafez Bajoghli  4 , Edith Holsboer-Trachsler  5 , Serge Brand  6
Affiliations

Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial

Vahid Farnia et al. Neuropsychiatr Dis Treat. .

Abstract

Background: A substantial disadvantage of psychopharmacological treatment of major depressive disorder (MDD) with selective serotonin-reuptake inhibitors (SSRIs) is the impact on sexual dysfunction. The aim of the present study was to investigate whether the oil of Rosa damascena can have a positive influence on SSRI-induced sexual dysfunction (SSRI-I SD) of male patients who are suffering from MDD and are being treated with SSRIs.

Method: In a double-blind, randomized, and placebo-controlled clinical trial, a total of 60 male patients treated with an SSRI and suffering from MDD (mean age =32 years) and SSRI-I SD were randomly assigned to take either verum (R. damascena oil) or a placebo. Patients completed self-ratings of depression and sexual function at baseline, at 4 weeks later, and at the end of the study, 8 weeks after it started.

Results: Over time, sexual dysfunction improved more in the verum group than in the control group. Improvements were observed in the verum group from week 4 to week 8. Self-rated symptoms of depression reduced over time in both groups, but did so more so in the verum group than in the control group.

Conclusion: This double-blind, randomized, and placebo-controlled clinical trial showed that the administration of R. damascena oil ameliorates sexual dysfunction in male patients suffering from both MDD and SSRI-I SD. Further, the symptoms of depression reduced as sexual dysfunction improved.

Keywords: Rosa damascena oil; SSRI-induced sexual dysfunction; major depressive disorder; selective serotonin-reuptake inhibitors; sexual dysfunction.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT diagram showing the flow of participants through each stage. Abbreviations: n, number of subjects; CONSORT, Consolidated Standards of Reporting Trials.
Figure 2
Figure 2
Comparison of sexual function between verum and placebo groups. Notes: Over time, sexual dysfunction improved significantly more in the verum (Rosa damascena oil) group than in the placebo group. Points are means, and bars are standard errors.
Figure 3
Figure 3
Comparison of BDI scores between verum and placebo groups. Notes: Over time, symptoms of depression (BDI scores) decreased significantly more in the verum (Rosa damascena extract) group than in the placebo group. Points are means, and bars are standard deviations. Abbreviation: BDI, Beck Depression Inventory.
See this image and copyright information in PMC

References

    1. Josefsson T, Lindwall M, Archer T. Physical exercise intervention in depressive disorders: meta-analysis and systematic review. Scand J Med Sci Sports. 2014;24(2):259–272. - PubMed
    1. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet. 1997;349(9063):1436–1442. - PubMed
    1. Johannes CB, Clayton AH, Odom DM, et al. Distressing sexual problems in United States women revisited: prevalence after accounting for depression. J Clin Psychiatry. 2009;70(12):1698–1706. - PubMed
    1. Bonierbale M, Lançon C, Tignol J. The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr Medl Res Opin. 2003;19(2):114–124. - PubMed
    1. Angst J. Sexual problems in healthy and depressed persons. Int Clin Psychopharmacol. 1998;13(Suppl 6):S1–S4. - PubMed

LinkOut - more resources